This announcement is a separate document:
西部证券股份有限公司关于圣湘生物科技股份有限公司2023年年度报告信息披露监管问询函回复的核查意见
Verification opinion on the reply to the regulatory inquiry letter on the disclosure of information in the 2023 annual report of sansure biotech inc. by western securities limited.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.